CBMG insider filings

Cellular Biomedicine Group, Inc. — 9 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-02-19. Screen CBMG transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for CBMG between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Cellular Biomedicine Group, Inc.

FiledFormInsiderReported transactionsSource
2021-02-194Au Chun Kwok Alan — DirectorDisposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 5,056 (derivative) · Disposition to issuer (D): 2,060 (derivative) · Disposition to issuer (D): 9,789 (derivative) · Disposition to issuer (D): 12,056 (derivative) · Disposition to issuer (D): 7,213 (derivative) · +3 moreEDGAR
2021-02-194Ji Gang Jacky — DirectorDisposition to issuer (D): 3,620 (derivative) · Disposition to issuer (D): 4,926 (derivative) · Disposition to issuer (D): 2,947 (derivative) · Disposition to issuer (D): 3,133 (derivative) · Disposition to issuer (D): 5,543 (derivative)EDGAR
2021-02-194Belmont Terry — DirectorDisposition to issuer (D): 3,000 (derivative) · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 8,761 (derivative) · Disposition to issuer (D): 11,895 (derivative) · Disposition to issuer (D): 14,648 (derivative) · Disposition to issuer (D): 8,765 (derivative) · +2 moreEDGAR
2021-02-194Zhou Hansheng — DirectorDisposition to issuer (D): 5,300 (derivative) · Disposition to issuer (D): 12,056 (derivative) · Disposition to issuer (D): 7,213 (derivative) · Disposition to issuer (D): 6,019 (derivative) · Disposition to issuer (D): 6,976 (derivative)EDGAR
2021-02-194Liu Wen Tao — DirectorDisposition to issuer (D): 213,076 · Disposition to issuer (D): 146,667 (derivative) · Disposition to issuer (D): 5,477 (derivative) · Disposition to issuer (D): 6,348 (derivative)EDGAR
2021-02-194Yao Yihong — Chief Scientific OfficerGrant/award (A): 54,000 @ $0 · Other (J): 88,549 · Disposition to issuer (D): 18,900 · Other (J): 25,000 (derivative) · Other (J): 10,000 (derivative) · Other (J): 26,500 (derivative)EDGAR
2021-02-194Chan Andrew K — Ch Legal Ofr, Corp Dev & SecGrant/award (A): 48,000 @ $0 · Disposition to issuer (D): 239,747 · Disposition to issuer (D): 38,880 (derivative) · Disposition to issuer (D): 37,904 (derivative) · Other (J): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +1 moreEDGAR
2021-02-194Liu Tony — CEO, CFO, DirectorGrant/award (A): 240,000 @ $0 · Other (J): 476,817 · Disposition to issuer (D): 10,700 · Other (J): 5,300 (derivative) · Other (J): 255,000 (derivative) · Other (J): 15,000 (derivative) · +6 moreEDGAR
2021-02-194Schafer Edward T — DirectorDisposition to issuer (D): 5,044 (derivative) · Disposition to issuer (D): 4,983 (derivative)EDGAR

Recent 8-K events — Cellular Biomedicine Group, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2021-02-198-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-02-088-K5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2021-02-018-K8.01 — Other EventsEDGAR
2021-01-298-K8.01 — Other EventsEDGAR
2020-12-048-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2020-10-268-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2020-08-288-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2020-08-128-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CBMG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs